Cargando…
Extremes of Clinical and Enzymatic Phenotypes in Children With Hyperinsulinism Caused by Glucokinase Activating Mutations
OBJECTIVE: Heterozygous activating mutations of glucokinase have been reported to cause hypoglycemia attributable to hyperinsulinism in a limited number of families. We report three children with de novo glucokinase hyperinsulinism mutations who displayed a spectrum of clinical phenotypes correspond...
Autores principales: | Sayed, Samir, Langdon, David R., Odili, Stella, Chen, Pan, Buettger, Carol, Schiffman, Alisa B., Suchi, Mariko, Taub, Rebecca, Grimsby, Joseph, Matschinsky, Franz M., Stanley, Charles A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682682/ https://www.ncbi.nlm.nih.gov/pubmed/19336674 http://dx.doi.org/10.2337/db08-1792 |
Ejemplares similares
-
Clinical Heterogeneity in Monogenic Diabetes Caused by Mutations in the Glucokinase Gene (GCK-MODY)
por: Cuesta-Muñoz, Antonio L., et al.
Publicado: (2010) -
Ebb and Tide of Glucokinase
por: Matschinsky, Franz M.
Publicado: (2001) -
Glucokinase Activators for Diabetes Therapy: May 2010 status report
por: Matschinsky, Franz M., et al.
Publicado: (2011) -
Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations
por: Li, Changhong, et al.
Publicado: (2023) -
Glucokinase activators (GKAs) promise a new pharmacotherapy for diabetics
por: Matschinsky, Franz M, et al.
Publicado: (2010)